A modified spacer device for inhalational drug therapy for chronic bronchitis/asthma in laryngectomised patients.
Following total laryngectomy, patients who need to continue their inhalational drug therapy for chronic pulmonary conditions experience a great deal of difficulty in administering the drugs. We describe a new spacer device to deliver inhalational drug therapy to laryngectomized patients which is simple to use and does not interfere with the patient's life style. The device involves a standard metered dose inhaler, a paediatric face mask and a small volume spacer. This device was used successfully in six laryngectomised patients for 12-18 months, who needed to continue their inhalational drug therapy for their pulmonary condition.
Nandapalan
V
V
Department of Otolaryngology, Aintree Hospital Trust, Aintree, UK.
Currey
M
M
Jones
T M
TM
D000280:Administration, Inhalation; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D004867:Equipment Design; D006801:Humans; D007825:Laryngectomy; D009330:Nebulizers and Vaporizers